Investor Information

IR banner
Webcast ImageWebcast - Replay
Q2 2017 Express Scripts Holding Co Earnings Conference Call
07/26/17 at 8:30 a.m. ET
Q2 2017 Express Scripts Holding Co Earnings Conference Call
Wednesday, July 26, 2017 8:30 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

Business Overview

Business Overview
At Express Scripts we believe in practicing pharmacy smarter. We put medicine within reach of tens of millions of people by aligning with our customers, taking bold action and delivering patient-centered care to make better health more affordable and accessible.

Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.

Stock chart for: ESRX.O.  Currently trading at $61.05 with a 52 week high of $77.61 and a 52 week low of $57.80.
ESRX (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$61.05
Change (%) Stock is Down 0.57 (0.93%)
Volume1,456,186
Data as of 08/23/17 3:18 p.m. ET
Refresh quote
Recent Press Releases
Express Scripts Named a Best Place to Work for Disability Inclusion - 08/23/2017 - 8:05 a.m.
ST. LOUIS, Aug. 23, 2017 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) was recognized today as a top-scoring company on the Disability Equality Index® (DEI) for having inclusive workplace, social and... 
The Value of Active Pharmacy Management: Express Scripts 2018 National Preferred Formulary - 07/31/2017 - 9:15 a.m.
ST. LOUIS, July 31, 2017 Deciding which medicines to include on the nation's largest drug list starts where it should: by determining which medicines deliver the best outcomes for patients. Experi... 
Express Scripts Announces 2017 Second Quarter Results - 07/25/2017 - 4:03 p.m.
ST. LOUIS, July 25, 2017 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced 2017 second quarter net income of $801.8 million or $1.37 per diluted share.  2017 second quarter adju... 
Express Scripts Holding Company Announces Second Quarter 2017 Earnings Conference Call - 07/06/2017 - 2:03 p.m.
St. Louis, July 06, 2017 (GLOBE NEWSWIRE) -- Express Scripts Holding Company (Nasdaq: ESRX) (“Express Scripts”) announced today its intention to release its 2017 second quarter financial results... 
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Express Scripts Holding Co posts new information to the site. Just enter your e-mail address and click Submit.
 

Tax Consequences of Express Scripts and Medco Merger

Investor Overview
Learn more about Express Scripts and find corporate and shareholder information.

Data provided by Nasdaq. Minimum 15 minutes delayed.
Print Page Print | E-mail Page E-mail Page | RSS Feeds RSS | E-mail Alerts Alerts | IR Contacts IR Contacts | Financial Tear Sheet Financial Tear Sheet